FAIRFIELD, Conn., Jan. 14 /PRNewswire-FirstCall/ -- Competitive Technologies, Inc. (Amex: CTT) held its annual meeting today at the American Stock Exchange in New York City. Richard E. Carver, CTT's Chairman of the Board, and John B. Nano, President and CEO described the key aspects of the 2005 business plan which is expected to lead to double-digit growth in revenue and net income when compared to fiscal 2004 financial results. The full slide presentation is available on the Investors page at CTT's website: http://www.competitivetech.net . "The CTT business team is actively fulfilling its commitment of growth and achieving our strategic vision," said Mr. Carver. "Shareholders are beginning to realize value from their investment in CTT as the market recognizes the outstanding work being done at the company. The stock price for 2004 closed at $11.10, an improvement of 345.8% over the $2.49 closing at year-end 2003. We are proud to have the two new members elected to our Board, Drs. Maria-Luisa Maccecchini who brings to CTT a strong background in the important biotech industry and Donald J. Freed, who is currently the Executive Vice President and Chief Technology Officer at CTT. We also wish to thank Samuel M. Fodale for his past service to the company as he steps down from the Board." Mr. Nano said, "As we continue to successfully implement our business plan, we expect fiscal 2005 to be even stronger than the exciting and profitable year we achieved in fiscal 2004. Our objective is double-digit growth in revenue and net income for fiscal 2005 ending July 31, 2005. I believe that CTT's stock is trading at a very low p/e considering our trailing four quarters of earnings of $0.55 per share." "We are building a strong, recurring revenue stream, successfully capitalizing on the technology and business expertise of our commercialization team, and are well positioned in a global licensing market that demands the dynamic technologies that are in our portfolio," continued Mr. Nano. "We are expanding our portfolio with quality, innovative technologies including the just-announced RFID tracking technology, the homocysteine assay, where we recently signed new royalty and license fee agreements, MPEG-4 video compression and decoding technology, where we recently incorporated a second patent into the License Pool, silicon carbide wafer testing, a sexual dysfunction therapeutic, encryption technology, a sunless tanning technology, a nanotechnology bone biomaterial, an anticancer compound and the Therapik(R) medical device. Our plan is to continue to leverage near-term opportunities while executing our longer-term strategies for sustained growth and increased shareholder value." About Competitive Technologies, Inc. Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider focused on the technology needs of its customers and transforming those requirements into commercially viable solutions. CTT is a global leader in identifying, developing and commercializing innovative technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. The global market for technology transfer services is estimated at $150 billion annually. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: http://www.competitivetech.net . Statements about our future expectations, including development and regulatory plans, and all other statements in this document other than historical facts are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. These statements involve risks and uncertainties inherent in our business, including those set forth in Item 7 under the caption "Risk Factors," in our most recent Annual Report on Form 10-K filed with the SEC on October 29, 2004, and other factors that may be described in our other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement. Direct inquiries to: Johnnie D. Johnson, E-mail: email@example.com Strategic IR, Inc. Tel. (212) 754-6565; E-mail: firstname.lastname@example.org Fax (212) 754-4333
SOURCE Competitive Technologies, Inc.